Caprion Aquires Biomarker Business from PPD

Caprion Proteomics Inc. announced today that it has acquired from PPD, Inc. (Nasdaq: PPDI) the shares and assets of PPD Biomarker Discovery Sciences, LLC, PPD’s proteomics-based biomarker services division based in Menlo Park, Calif. The acquisition, which closed on December 31, 2009, further strengthens Caprion’s market leadership position in the area of proteomics biomarker services and will also broaden its client portfolio and revenue base. Financial terms of the acquisition were not disclosed.

Source: Caprion Proteomics